Weight loss drug semaglutide may reduce alcohol cravings, heavy drinking and smoking, new study finds
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol.
Can weight-loss drug Ozempic help reduce alcohol consumption?
A new study published in the JAMA Psychiatry gives the strongest evidence that semaglutide — the active ingredient in Ozempic and the weight-loss drug Wegovy — could genuinely help individuals struggling with alcohol addiction drink less and crave alcohol less frequently.
Ozempic 'Significantly' Lowered 'Alcohol Craving' in First Clinical Trial, with Those Taking the Drug Drinking 40% Less
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of alcohol consumed when someone on the drug does drink
Semaglutide Shows Promise in Reducing Alcohol Cravings and Consumption
A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol consumption.
Weight loss drugs could help reduce alcohol cravings, study finds
Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern California looked at a positive side
Ozempic Shows Some Promise for Alcohol Use Disorder
But when averaging the number of drinks only on the days alcohol was consumed, the reduction was greater in the Ozempic group. And over time, there was a greater reduction in heav
Low doses of Ozempic help to reduce alcohol consumption, Bloomberg reports
A study of 48 people with signs of moderate alcohol-use disorder found that those taking low doses of semaglutide, currently produced by Novo
Ozempic shown to reduce drinking in first trial in alcohol-use disorder
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.
Ozempic’s key ingredient may reduce the desire to drink alcohol
In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.
Ozempic’s Active Ingredient May Reduce Alcohol Cravings, Study Says
The active ingredient in Ozempic and Wegovy was linked to reduced cravings for drinking alcohol among people with alcohol use disorder, according to a small study published Wednesday in the journal JAMA Psychiatry,
Blockbuster weight loss drugs could help with alcohol cravings, small new study suggests
The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews ...
News Medical2d
What's Next for Semaglutide? Beyond Diabetes and Weight Loss
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Weight-Loss Drugs Like Ozempic Can Help Alcohol Addiction
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
Ozempic can curb drinking, new research shows
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
Some Ozempic users are developing serious eye issues that lead to blindness
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.
Obesity drugs may help people drink less alcohol: Study
A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...
Medscape3h
Weight Loss Drug Curbs Alcohol Cravings, Consumption
Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...
Hosted on MSN6h
Weight Loss At A Cost: Study Reveals Link Between Ozempic And Vision Loss
A recent study suggests a potential link between Ozempic and vision loss, particularly non-arteritic anterior ischemic optic ...